Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies
Clinical trial NCT00943592 · COMPLETED
Trial details
- NCT number
- NCT00943592
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2011-04-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.